Anti-Human CD45RO [UCHL-1] In Vivo Antibody - Low Endotoxin
- SKU:
- IVMB0311
- Product Type:
- In Vivo Monoclonal Antibody
- Clone:
- UCHL-1
- Protein:
- CD45RO
- Isotype:
- IgG2a
- Reactivity:
- Human
- Synonyms:
- B220
- Research Area:
- Cell Biology
- Immunology
- Inhibitory Molecules
- Neuroscience
- Neuroscience Cell Markers
- Stem Cell
- Endotoxin Level:
- Low Endotoxin
- Host Species:
- Mouse
- Applications:
- FC
- IHC FF
- IHC FFPE
- In Vivo
- IP
- PhenoCycler
- WB
Description
Product Name: | Anti-Human CD45RO (Clone UCHL-1) In Vivo Antibody - Low Endotoxin |
Product Code: | IVMB0311 |
Size: | 1 mg, 5 mg, 25 mg, 50 mg, 100 mg |
Clone: | UCHL-1 |
Protein: | CD45RO |
Product Type: | Monoclonal Antibody |
Synonyms: | B220 |
Isotype: | IgG2a |
Reactivity: | Human |
Applications: | FC, IHC FF, IHC FFPE, In Vivo, IP, PhenoCycler®, WB |
Formulation: | This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added. Due to inherent biochemical properties of antibodies, certain products may be prone to precipitation over time. Precipitation may be removed by aseptic centrifugation and/or filtration. |
Endotoxin Level: | < 1.0 EU/mg as determined by the LAL method |
Purity: | ≥95% monomer by analytical SEC ⋅ >95% by SDS Page |
Product Preparation: | Functional grade preclinical antibodies are manufactured in an animal free facility using in vitro cell culture techniques and are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates. |
Applications: | FC, IHC FF, IHC FFPE, In Vivo, IP, PhenoCycler®, WB |
Reactivity: | Human |
Host Species: | Mouse |
Specificity: | Clone UCHL-1 recognizes human CD45RO. |
Antigen Distribution: | The CD45RO antigen is present on most thymocytes, about 40% of resting peripheral blood T-lymphocytes and the majority of T-cells in skin reactive infiltrates and T-cell malignancies. CD45RO is also found on a subset of B-cells and some B-cell lymphomas. NK cells do not express the CD45RO antigen. It is also present on monocytes, macrophages and granulocytes. |
Concentration: | ≥ 5.0 mg/ml |
Endotoxin Level: | < 1.0 EU/mg as determined by the LAL method |
Formulation: | This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added. Due to inherent biochemical properties of antibodies, certain products may be prone to precipitation over time. Precipitation may be removed by aseptic centrifugation and/or filtration. |
Purity: | ≥95% monomer by analytical SEC ⋅ >95% by SDS Page |
Preparation: | Functional grade preclinical antibodies are manufactured in an animal free facility using in vitro cell culture techniques and are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates. |
Storage and Handling: | Functional grade preclinical antibodies may be stored sterile as received at 2-8°C for up to one month. For longer term storage, aseptically aliquot in working volumes without diluting and store at -80°C. Avoid Repeated Freeze Thaw Cycles. |